Pediatric Critical Care 2018
DOI: 10.1007/978-3-319-96499-7_11
|View full text |Cite
|
Sign up to set email alerts
|

Management of Fluid Overload in the Pediatric ICU

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 51 publications
0
2
0
Order By: Relevance
“…Finally, renal perfusion may be compromised, especially under stressful situations, leading to the development of acute kidney injury, which makes it more difficult for the kidneys to maintain euvolemia. 17 Hayes described in his study that in children with end-stage kidney disease, dysregulation of intravascular fluid volume leads to cardiovascular morbidity and eventually mortality. The most frequent cause of death in children receiving dialysis is cardiovascular problems.…”
Section: Evidence From Literature For Adverse Effects Of Fluid Overloadmentioning
confidence: 99%
“…Finally, renal perfusion may be compromised, especially under stressful situations, leading to the development of acute kidney injury, which makes it more difficult for the kidneys to maintain euvolemia. 17 Hayes described in his study that in children with end-stage kidney disease, dysregulation of intravascular fluid volume leads to cardiovascular morbidity and eventually mortality. The most frequent cause of death in children receiving dialysis is cardiovascular problems.…”
Section: Evidence From Literature For Adverse Effects Of Fluid Overloadmentioning
confidence: 99%
“…29 Ethacrynic acid is a non-sulfonamide loop diuretic that is less commonly used due to concern for increased ototoxicity and cost. 30,31 The loop diuretics furosemide and ethacrynic acid are labelled for use as diuretics in paediatric populations: Intravenous and oral furosemide are labelled by the Food and Drug Administration for the treatment of oedema in paediatric patients of all ages with congestive heart failure, hepatic cirrhosis, and renal disease, 32 and oral ethacrynic acid is Food and Drug Administration-labelled for the short-term management of oedema in hospitalised paediatric patients with CHD or nephrotic syndrome. 33 Notably, both intravenous and oral ethacrynic acid are contraindicated for use in infants by Food and Drug Administration labelling.…”
Section: Loop Diureticsmentioning
confidence: 99%